T1	Participants 85 107	small cell lung cancer
T2	Participants 111 160	Eighty-three patients with small cell lung cancer
T3	Participants 347 387	74 patients were availble to be analysis
T4	Participants 389 473	The two treatment groups were well-matched in age, sex, stage and performance status
